Article
Limitations of acyclovir and identification of potent HSV antivirals using 3D bioprinted human skin equivalents
2024-12-09
Abstract excerpt
Herpes simplex virus (HSV) infection has worldwide public health concerns and lifelong medical impacts. The standard therapy, acyclovir, has limited efficacy in preventing HSV subclinical virus shedding, and drug resistance occurs in immunocompromised patients, highlighting the need for novel therapeutics. HSV manifests in the skin and mucosal epithelium. Here, we found acyclovir significantly less effective in sk...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 22611bdc-fa5a-5d31-9c55-eb3a64e026d9
- DOI
- 10.1101/2024.12.04.626896
